5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | NEUTRAL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.51▼ | 1.51▼ | 1.51▼ | 1.50▼ | 1.42▲ |
MA10 | 1.50▼ | 1.50▼ | 1.50▼ | 1.44▲ | 1.54▼ |
MA20 | 1.50▼ | 1.51▼ | 1.50▼ | 1.41▲ | 1.56▼ |
MA50 | 1.47▲ | 1.43▲ | 1.39▲ | 1.61▼ | 2.18▼ |
MA100 | 1.39▲ | 1.40▲ | 1.41▲ | 1.57▼ | 3.30▼ |
MA200 | 1.41▲ | 1.48▲ | 1.57▼ | 1.98▼ | 63.54▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | -0.006▼ | -0.006▼ | 0.028▲ | 0.038▲ |
RSI | 47.388▼ | 50.184▲ | 52.585▲ | 51.486▲ | 43.478▼ |
STOCH | 66.667 | 48.333 | 45.000 | 72.436 | 15.555▼ |
WILL %R | -90.000▼ | -90.000▼ | -90.000▼ | -31.926 | -77.727▼ |
CCI | -95.761 | -72.836 | -79.265 | 82.668 | -51.854 |
Wednesday, September 03, 2025 08:25 PM
(Reuters) -Exchange operator Nasdaq proposed on Wednesday stricter listing standards, including a higher minimum public float for certain new listings and a faster process to suspend and delist thinly ...
|
Monday, August 25, 2025 08:09 AM
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Galmed ...
|
Monday, August 25, 2025 05:30 AM
TEL AVIV, Israel, Aug. 25, 2025 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for the treatment of liver, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/09/25 | 1.50 | 1.545 | 1.47 | 1.485 | 64,365 |
16/09/25 | 1.42 | 1.52 | 1.42 | 1.48 | 68,385 |
15/09/25 | 1.51 | 1.56 | 1.45 | 1.46 | 80,020 |
12/09/25 | 1.55 | 1.5999 | 1.50 | 1.51 | 59,366 |
11/09/25 | 1.41 | 1.55 | 1.41 | 1.55 | 127,364 |
10/09/25 | 1.46 | 1.4955 | 1.40 | 1.41 | 186,023 |
09/09/25 | 1.34 | 1.47 | 1.34 | 1.455 | 204,327 |
08/09/25 | 1.36 | 1.40 | 1.335 | 1.3699 | 111,398 |
05/09/25 | 1.27 | 1.3796 | 1.26 | 1.36 | 62,078 |
04/09/25 | 1.30 | 1.31 | 1.25 | 1.28 | 37,502 |
|
|
||||
|
|
||||
|
|